[1]
Ferraris, A. et al. 2017. Off-label use of rituximab and associated factors in adult patients: a pilot study. Revista del Hospital Italiano de Buenos Aires. 37, 4 (Dec. 2017), 129–135. DOI:https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v37i4.599.